These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20016431)

  • 1. Surgical margins in breast conservation therapy: how much should we excise?
    Law TT; Kwong A
    South Med J; 2009 Dec; 102(12):1234-7. PubMed ID: 20016431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience.
    Sahoo S; Recant WM; Jaskowiak N; Tong L; Heimann R
    Breast J; 2005; 11(4):242-7. PubMed ID: 15982389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Margin status after breast-conserving treatment of breast cancer: how much free margin is enough?
    von Smitten K
    J Surg Oncol; 2008 Dec; 98(8):585-7. PubMed ID: 19072849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Locally recurrent breast cancer after conservation therapy.
    Huston TL; Simmons RM
    Am J Surg; 2005 Feb; 189(2):229-35. PubMed ID: 15720997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Who should not undergo breast conservation?
    Nijenhuis MV; Rutgers EJ
    Breast; 2013 Aug; 22 Suppl 2():S110-4. PubMed ID: 24074770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of specimen radiography in breast-conserving therapy of ductal carcinoma in situ.
    Lange M; Reimer T; Hartmann S; Glass Ä; Stachs A
    Breast; 2016 Apr; 26():73-9. PubMed ID: 27017245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
    Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal use of re-excision in patients diagnosed with early-stage breast cancer by excisional biopsy treated with breast-conserving therapy.
    Caughran JL; Vicini FA; Kestin LL; Dekhne NS; Benitez PR; Goldstein NS
    Ann Surg Oncol; 2009 Nov; 16(11):3020-7. PubMed ID: 19636632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Margins in breast cancer: How much is enough?
    Pilewskie M; Morrow M
    Cancer; 2018 Apr; 124(7):1335-1341. PubMed ID: 29338088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local control in ductal carcinoma in situ treated by excision alone: incremental benefit of larger margins.
    MacDonald HR; Silverstein MJ; Mabry H; Moorthy B; Ye W; Epstein MS; Holmes D; Silberman H; Lagios M
    Am J Surg; 2005 Oct; 190(4):521-5. PubMed ID: 16164913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective use of whole breast radiotherapy after breast conserving surgery for invasive breast cancer and DCIS.
    Skandarajah AR; Bruce Mann G
    Surgeon; 2013 Oct; 11(5):278-85. PubMed ID: 23632044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Margin width as the sole determinant of local recurrence after breast conservation in patients with ductal carcinoma in situ of the breast.
    Macdonald HR; Silverstein MJ; Lee LA; Ye W; Sanghavi P; Holmes DR; Silberman H; Lagios M
    Am J Surg; 2006 Oct; 192(4):420-2. PubMed ID: 16978941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The surgical margin status after breast-conserving surgery: discussion of an open issue.
    Luini A; Rososchansky J; Gatti G; Zurrida S; Caldarella P; Viale G; Rosali dos Santos G; Frasson A
    Breast Cancer Res Treat; 2009 Jan; 113(2):397-402. PubMed ID: 18386174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of margin status on local recurrence after mastectomy for ductal carcinoma in situ.
    Childs SK; Chen YH; Duggan MM; Golshan M; Pochebit S; Punglia RS; Wong JS; Bellon JR
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):948-52. PubMed ID: 22975615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining the clinical target volume for patients with early-stage breast cancer treated with lumpectomy and accelerated partial breast irradiation: a pathologic analysis.
    Vicini FA; Kestin LL; Goldstein NS
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):722-30. PubMed ID: 15465188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ipsilateral local recurrence in relation to therapy and morphological characteristics in patients with ductal carcinoma in situ of the breast.
    Ringberg A; Idvall I; Fernö M; Anderson H; Anagnostaki L; Boiesen P; Bondesson L; Holm E; Johansson S; Lindholm K; Ljungberg O; Ostberg G
    Eur J Surg Oncol; 2000 Aug; 26(5):444-51. PubMed ID: 11016463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast conservation in ductal carcinoma in situ (DCIS): what defines optimal margins?
    Toss MS; Pinder SE; Green AR; Thomas J; Morgan DA; Robertson JF; Ellis IO; Rakha EA
    Histopathology; 2017 Apr; 70(5):681-692. PubMed ID: 28000325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Margin index is not a reliable tool for predicting residual disease after breast-conserving surgery for DCIS.
    Fisher CS; Klimberg VS; Khan S; Gao F; Margenthaler JA
    Ann Surg Oncol; 2011 Oct; 18(11):3155-9. PubMed ID: 21947593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sampling of secondary margins decreases the need for re-excision after partial mastectomy.
    Guidroz JA; Larrieux G; Liao J; Sugg SL; Scott-Conner CE; Weigel RJ
    Surgery; 2011 Oct; 150(4):802-9. PubMed ID: 22000194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcome after selective treatment of patients diagnosed with ductal carcinoma in situ of the breast.
    Meijnen P; Oldenburg HS; Peterse JL; Bartelink H; Rutgers EJ
    Ann Surg Oncol; 2008 Jan; 15(1):235-43. PubMed ID: 17987342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.